Logo Rosalind & Morris Goodman Cancer Institute
News - Thumbnail

The GCI Stands Out as Home to Six Vanier Scholars as Trainees Excel in Securing National and Provincial Funding Awards

July 07 2024

News
The Rosalind and Morris Goodman Cancer Institute (GCI) is nurturing excellence among early-career cancer researchers, a commitment underscored by its impressive cohort of Vanier Scholars. With six Vanier Scholars among its ranks, the GCI stands out as a beacon of excellence, especially given its relatively small number of researchers. 
Read more
News - Thumbnail

GCI Trainee Alexandre Poirier Receives the 2024 Prix Acfas Relève – Health Sciences Division

July 04 2024

News
The Prix Acfas Relève recognizes the diversity and richness of the scientific paths taken by our next generation of researchers in Quebec and in Canada. This year, five graduate trainees received this Award at the University of Ottawa, including the Rosalind and Morris Goodman Cancer Institute’s (GCI) Alexandre Poirier. Alex is currently completing his PhD in Experimental Medicine under the supervision of Prof. Michel Tremblay. 
Read more
News - Thumbnail

Empowering Future Scientists: GCI Alumnus Jason Northey’s Commitment to Cancer Research and Mentorship

June 26 2024

News
Jason Northey, an alumnus of the Rosalind and Morris Goodman Cancer Institute (GCI), shares with us his cancer research path to establishing his own research lab. From his graduate studies under the mentorship of Prof. Peter Siegel to his current endeavors, Jason underscores his commitment to understanding the intricate mechanisms of cancer progression and his dedication to mentoring the next generation of researchers.
Read more
News - Thumbnail

Guojun Chen Receives Canada Research Chair in Biomaterials and Biomacromolecule Delivery

June 20 2024

News
Prof. Guojun Chen, principal investigator at the Rosalind and Morris Goodman Cancer Institute (GCI), was among the newly announced Canada Research Chairholders as the Canada Research Chairholder in Biomaterials and Biomacromolecule Delivery.
Read more
News - Thumbnail

World Brain Tumour Day

June 08 2024

News
June 8th is World Brain Tumour Day! The “Deutsche Hirntumorhilfe e.V.” (German Brain Tumor Association) started this international commemoration day in the year 2000 as a tribute to all brain tumour patients and their families. It is our pleasure to be a part of this global initiative and help raise awareness around the world. Check out our interview with trainee Alexander Nowakowski to learn about his ongoing research into metastatic brain tumours at the Rosalind and Morris Goodman Cancer Institute (GCI). 
Read more
News - Thumbnail

Michel L. Tremblay and collaborators secure millions in funding through Genome Canada’s Genomics Application Partnership Program

May 30 2024

News

A project led by Michel L. Tremblay, Ph.D., principal investigator at the Rosalind and Morris Goodman Cancer Institute (GCI), secured major funding from Genome Canada’s Genomics Applications Partnership Program (GAPP). The project, entitled ‘Establishing therapeutic cord blood-derived NK cells for hard-to-treat cancers through omics based and pharmacological activators’ is co-led by McGill University’s David Langlais, Ph.D., and conducted in partnership with Kanyr Pharma Inc. and Dr. Pierre Laneuville, M.D., and Linda Peltier, Ph.D., from the McGill University Health Centre.

Read more
News - Thumbnail

Building Scientists in Quebec: GCI Alumnus Continues to Find a Cure for Cancer

May 14 2024

News

In the continuously developing landscape of cancer research, the Rosalind and Morris Goodman Cancer Institute (GCI) stands out as a nurturing ground for talent in the heart of Montreal. A testament of the GCI’s commitment to providing cutting-edge research training, alumnus Dominic Roy shares his journey from a postdoctoral fellow at the GCI to now an independent investigator in the Cancer Axis at the CHUM Research Centre in affiliation with Université de Montréal.

Read more